SUBPART B. DISCLOSURE OF PRESCRIPTION DRUG
PRICE INFORMATION
§2255.11. Disclosure of prescription drug price information
Each drug manufacturer or pharmaceutical marketer who engages in any form of
prescription drug marketing to a prescriber, his designee, or any member of his staff in
Louisiana shall provide to the Louisiana Board of Pharmacy no later than January first, April
first, July first, and October first of each calendar year the current wholesale acquisition cost
information for the United States Food and Drug Administration approved drugs marketed
in the state by that manufacturer.
Acts 2017, No. 220, §1.